RecallDepth
Class III Completed

Bendamustine HCl Injection, 100mg/4mL (25mg/mL), One 4 mL Multiple-Dose Vial, Rx only, Manufactured for Baxter Healthcare Corporation, Deerfield, IL 60015, NDC 10019-079-01.

Company
Baxter Healthcare Corporation
Recall Initiated
August 14, 2023
Posted
August 30, 2023
Recall Number
D-1103-2023
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
13,502 vials
Firm Location
Deerfield, IL, United States

Reason for Recall

Labeling: Missing Label; customer complaint received that labels were partially or completely peeled off injection vial.

Distribution

Nationwide in the U.S.A.

Lot / Code Info

Lots: 3A004A, 3A004B, Exp 12/31/2024; 3B005A, Exp 1/31/2025

More recalls by Baxter Healthcare Corporation

View all recalls by this company →

Other recent Class III Drug recalls